290 results on '"Pouteil Noble, C"'
Search Results
2. Questions raised by the exclusion of ‘at risk’ conditions from current trials in organ transplantation
3. Is there any relationship between the early glomerular filtration rate and late graft dysfunction in renal transplantation?
4. Skin Cancers in Organ Transplant Recipients
5. Renal Transplantation in Patients With AA Amyloidosis Nephropathy: Results From a French Multicenter Study
6. Impact of Pretransplant Human Leukocyte Antigen-C and -DP Antibodies on Kidney Graft Outcome
7. Can we select candidates for combined kidney and heart or liver transplantation?
8. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis
9. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation
10. Analyse du complément chez des patients ayant une microangiopathie thrombotique associée au lupus : identification de variants rares du facteur I
11. Impact de l’induction par anticorps polyclonaux anti-lymphocytes T sur la récidive de la néphropathie à IgA : étude PIRAT
12. WHICH PLACE OF PANCREAS GRAFT BIOPSY IN THE MANAGEMENT OF PANCREAS TRANSPLANT RECIPIENTS?: 5
13. Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?
14. Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study
15. Sirolimus Conversion for Patients with Posttransplant Kaposi's Sarcoma
16. Tolerability of Enteric-Coated Mycophenolate Sodium to 1 Year in Combination With Cyclosporine and Corticosteroids in Renal Transplant Recipients
17. Profils de syndromes hémolytique et urémique associés aux maladies systémiques auto-immunes : une analyse transversale du registre français du CNR-MAT
18. Maladie de Kaposi et transplantation d’organes : 22 cas
19. Chronic Renal Failure and End-Stage Renal Disease Are Associated With a High Rate of Mortality After Heart Transplantation
20. The place of fetal liver transplantation in the treatment of inborn errors of metabolism
21. Combined Kidney Transplantation (Tx) with Heart, Liver or Pancreas
22. Graft dysfunction and polyomavirus infection in renal allograft recipients
23. BREAKTHROUGH IN THE MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION: A NATIONWIDE STUDY
24. Efficacité de l’éculizumab comme traitement de la microangiopathie thrombotique induite par la gemcitabine : à propos d’un cas
25. Incidence of hospital-acquired infections following kidney, pancreas or kidney-pancreas transplantations: A surveillance-based study
26. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
27. High Pretransplantation Soluble CD30 Levels: Impact in Renal Transplantation
28. Efficacité de l’éculizumab dans les microangiopathies thrombotiques induites par la gemcitabine. Expérience du Centre de référence français des microangiopathies thrombotiques
29. EP18 - Évaluation de la douleur chronique chez le donneur de rein vivant après néphrectomie
30. Switching from cyclosporine to tacrolimus in renal transplant recipients: impact on mycophenolic acid exposure
31. Confounding factors for early death in incident end-stage renal disease patients: Role of emergency dialysis start
32. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
33. Multicenter study of the renal transplantation selection process: multivariate analysis
34. Poor outcome in heart transplant patients with end-stage renal failure
35. Préparer les patients à la greffe rénale par un chemin clinique en dialyse : délai d’attente réduit ?
36. D-05: Surveillance des infections associées aux soins après transplantation de rein ou rein-pancréas
37. Protocole de l'étude NEPHRODIAB2
38. Post-transplant glomerular filtration rate as a marker for long-term outcome
39. Clinical correlation of acute rejection according to Banff classification in renal transplantation
40. Nosocomial transmission of Pneumocystis carinii in renal transplantation
41. L’intensité de l’exposition à l’acide mycophénolique est-elle un facteur de risque d’infection à BK virus ?
42. Sclérodermie et amylose AA : une association atypique ?
43. Profiling Sirolimus-Induced Inflammatory Syndrome: The SIRILYGRE Study
44. Effet du sirolimus sur la balance inflammatoire en transplantation rénale : étude sirilygre
45. Déterminants non médicaux associés au choix de la technique de dialyse
46. Greffe rénale chez les patients dont la néphropathie initiale est une amylose AA : étude rétrospective multicentrique française portant sur 59 patients
47. Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up
48. The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders
49. A Simple Modeling-free Method Provides Accurate Estimates of Sensitivity and Specificity of Longitudinal Disease Biomarkers
50. Évaluation des performances dépendantes du temps de la PCR quantitative pour prédire la maladie à CMV après transplantation rénale
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.